BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 11159099)

  • 21. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
    Kim YK; Kwak HS; Han YM; Kim CS
    J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with MR imaging and angiographically assisted CT.
    Kanematsu M; Osada S; Amaoka N; Goshima S; Kondo H; Moriyama N
    Abdom Imaging; 2006; 31(1):78-89. PubMed ID: 16317488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.
    Lee JM; Kim IH; Kwak HS; Youk JH; Han YM; Kim CS
    Korean J Radiol; 2003; 4(1):1-8. PubMed ID: 12679628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
    Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
    J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of factors influencing hepatocellular carcinoma detection: efficient use of computed tomography during arterial portography and during hepatic arteriography.
    Fujishima T; Yoshida H; Obi S; Shiina S; Kanda M; Tateishi R; Akamatsu M; Koike Y; Sato S; Teratani T; Kawabe T; Shiratori Y; Omata M
    J Gastroenterol; 2005 Mar; 40(3):266-73. PubMed ID: 15830286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined.
    Onishi H; Murakami T; Kim T; Hori M; Iannaccone R; Kuwabara M; Abe H; Nakata S; Osuga K; Tomoda K; Passariello R; Nakamura H
    Radiology; 2006 Apr; 239(1):131-8. PubMed ID: 16484347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography.
    Lencioni R; Donati F; Cioni D; Paolicchi A; Cicorelli A; Bartolozzi C
    MAGMA; 1998 Dec; 7(2):76-87. PubMed ID: 9951768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT.
    Kim YK; Kwak HS; Kim CS; Chung GH; Han YM; Lee JM
    Radiology; 2006 Feb; 238(2):531-41. PubMed ID: 16371577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
    Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
    Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.
    Ward J; Naik KS; Guthrie JA; Wilson D; Robinson PJ
    Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant hepatic tumor detection with ferumoxides-enhanced MR imaging with a 1.5-T system: comparison of four imaging pulse sequences.
    Kanematsu M; Itoh K; Matsuo M; Maetani Y; Ametani F; Kondo H; Kato H; Hoshi H
    J Magn Reson Imaging; 2001 Feb; 13(2):249-57. PubMed ID: 11169831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of hepatocellular carcinoma by ferumoxides-enhanced MR imaging in cirrhosis: Incremental value of dynamic gadolinium-enhancement.
    Qayyum A; Thoeni RF; Coakley FV; Lu Y; Guay JP; Ferrell LD
    J Magn Reson Imaging; 2006 Jan; 23(1):17-22. PubMed ID: 16315209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and characterization of hepatic tumors: value of combined helical CT hepatic arteriography and CT during arterial portography.
    Kanematsu M; Hoshi H; Imaeda T; Murakami T; Inaba Y; Yokoyama R; Nakamura H
    AJR Am J Roentgenol; 1997 May; 168(5):1193-8. PubMed ID: 9129410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performance of gadoxetic acid (Primovist)-enhanced MR imaging versus CT during hepatic arteriography and portography for small hypervascular hepatocellular carcinoma.
    Yim SY; Park BJ; Um SH; Han NY; Sung DJ; Cho SB; Lee SH; Kim MJ; Jung JY; Kim JD; Seo YS; Kim DS; An H; Kim YH
    Medicine (Baltimore); 2016 Sep; 95(39):e4903. PubMed ID: 27684824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity.
    Kato H; Kanematsu M; Kondo H; Goshima S; Matsuo M; Hoshi H; Moriyama N
    J Magn Reson Imaging; 2004 Jan; 19(1):76-81. PubMed ID: 14696223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of hepatic VX2 carcinomas with ferucarbotran-enhanced magnetic resonance imaging in rabbits: Comparison of nine pulse sequences.
    Kim SH; Choi D; Lim HK; Kim MJ; Jang KM; Kim SH; Lee WJ; Lee J; Jeon YH; Lim JH
    Eur J Radiol; 2006 Sep; 59(3):413-23. PubMed ID: 16678373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Will ferumoxides-enhanced MR imaging replace CT during arterial portography in the detection of hepatic metastases? Prologue to a promising future.
    Soyer P
    Radiology; 1996 Sep; 200(3):610-1. PubMed ID: 8756902
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation?
    Jang HJ; Lim JH; Lee SJ; Park CK; Park HS; Do YS
    Radiology; 2000 May; 215(2):373-80. PubMed ID: 10796910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM; Kim CS; Youk JH; Lee MS
    Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.